← All news
Markets
Ionis Pharmaceuticals Shares Fall After Pelacarsen Phase 3 Trial Misses Primary Endpoint
2 outlets - including Investing and Yahoo - are covering this story.
Covered by 2 outlets
All coverage · 4 articles
Investing.com Canada
·Sep 10, 06:30 UTC
Ondine Biomedical reports phase 3 trial meets primary endpoint
Investing.com News
·Sep 10, 06:29 UTC
Ondine Biomedical reports phase 3 trial meets primary endpoint
Investing.com Stock Market
·Sep 8, 21:50 UTC
Evommune stock tumbles after trial misses primary endpoint
Yahoo Finance News
·Sep 8, 10:54 UTC